Wealth Enhancement Advisory Services’s Altimmune ALT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-1,000
Closed -$606 2949
2024
Q3
$606 Buy
1,000
+500
+100% +$3.39K ﹤0.01% 2782
2024
Q2
$199 Buy
+500
New +$3.69K ﹤0.01% 2612

Other funds holding ALT

Wealth Enhancement Advisory Services's ALT Position: Q2 2026 in Review

Wealth Enhancement Advisory Services opened a new position in Altimmune (ALT) in Q2 2026: 25,989 shares worth $79.3K. The stake represents ﹤0.01% of the portfolio and ranks #3845 among its holdings. This is a return to the name: Wealth Enhancement Advisory Services previously reported a position in ALT as recently as Q2 2025.

Wealth Enhancement Advisory Services first reported a position in ALT in Q2 2024 and has held it in 6 quarters since. The position peaked at $118K in Q2 2025. 12 funds tracked by Wall St. Rank hold ALT as of Q2 2026.

  • Wealth Enhancement Advisory Services held 25,989 shares of Altimmune worth $79.3K as of Q2 2026.
  • Altimmune was a new Wealth Enhancement Advisory Services position in Q2 2026.
  • Altimmune made up ﹤0.01% of Wealth Enhancement Advisory Services's portfolio in Q2 2026, its #3845 holding.
  • Wealth Enhancement Advisory Services first reported a position in Altimmune in Q2 2024 and has held it in 6 quarters since.
  • Wealth Enhancement Advisory Services's Altimmune position peaked at $118K in Q2 2025.
  • 12 funds tracked by Wall St. Rank held Altimmune as of Q2 2026.

Based on Wealth Enhancement Advisory Services's 13F filing for Q2 2026, filed 15 Jul 2026.